Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
J Natl Med Assoc. 1993 May; 85(5): 349–352.
PMCID: PMC2571815
PMID: 8496988

Impact of intrauterine exposure to phencyclidine (PCP) and cocaine on neonates.

F. Rahbar, A. Fomufod, D. White, and L. S. Westney
Author information Copyright and License information PMC Disclaimer

Abstract

A total of 505 newborns who were exposed to illicit drugs during intrauterine life were studied to investigate the prevalence, growth parameters, newborn manifestations, and other effects of intrauterine exposure to cocaine and phencyclidine (PCP). The results support the hypotheses that both drugs have serious effects on growth parameters, but this effect was much more pronounced in the cocaine group than in the PCP group. Furthermore, the incidence of borderline microcephalic infants (head circumferences less than the 10th percentile) was much higher in the cocaine group. It also appears that the signs and symptoms observed in both groups are not withdrawal manifestations typically seen in narcotic-exposed infants; rather, these symptoms are true drug effects and should not be considered manifestations of drug withdrawal symptoms.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (598K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 349
349
icon of scanned page 350
350
icon of scanned page 351
351
icon of scanned page 352
352
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Rahbar F. Observations on methadone withdrawal in 16 neonates. Clin Pediatr (Phila) 1975 Apr;14(4):369–371. [PubMed] [Google Scholar]
  • Strauss AA, Modaniou HD, Bosu SK. Neonatal manifestations of maternal phencyclidine (PCP) abuse. Pediatrics. 1981 Oct;68(4):550–552. [PubMed] [Google Scholar]
  • Golden NL, Kuhnert BR, Sokol RJ, Martier S, Bagby BS. Phencyclidine use during pregnancy. Am J Obstet Gynecol. 1984 Feb 1;148(3):254–259. [PubMed] [Google Scholar]
  • Golden NL, Kuhnert BR, Sokol RJ, Martier S, Williams T. Neonatal manifestations of maternal phencyclidine exposure. J Perinat Med. 1987;15(2):185–191. [PubMed] [Google Scholar]
  • Rahbar F, Momeni J, Fomufod A, Westney L. Prenatal care and perinatal mortality in a black population. Obstet Gynecol. 1985 Mar;65(3):327–329. [PubMed] [Google Scholar]
  • Van Dyke C, Barash PG, Jatlow P, Byck R. Cocaine: plasma concentrations after intranasal application in man. Science. 1976 Feb 27;191(4229):859–861. [PubMed] [Google Scholar]
  • Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics. 1989 Aug;84(2):205–210. [PubMed] [Google Scholar]
  • Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973 Jun 9;1(7815):1267–1271. [PubMed] [Google Scholar]
  • Golden NL, Sokol RJ, Rubin IL. Angel dust: possible effects on the fetus. Pediatrics. 1980 Jan;65(1):18–20. [PubMed] [Google Scholar]
Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association
-